MEDICINE & HEALTH

Montefiore-Einstein Collab for Trials of Remdesivir-Baricitinib Combo as COVID-19 Cure

Montefiore Health System and Albert Einstein College of Medicine have begun with ACTT 2, a clinical trial using the drug combination remdesivir and baricitinib to treat patients with COVID-19. Researchers are hoping the new drug combo would reduce COVID-19-related inflammation and provide better recovery outcomes for coronavirus patients.

Recommended Stories